$249.52
1.32% day before yesterday
NYSE, May 16, 10:10 pm CET
ISIN
US50540R4092
Symbol
LH

Laboratory Stock price

$249.52
+28.95 13.13% 1M
+10.88 4.56% 6M
+20.20 8.81% YTD
+36.39 17.07% 1Y
+41.30 19.83% 3Y
+105.98 73.83% 5Y
+147.51 144.61% 10Y
NYSE, Closing price Fri, May 16 2025
+3.25 1.32%
ISIN
US50540R4092
Symbol
LH
Sector

Key metrics

Market capitalization $20.88b
Enterprise Value $27.04b
P/E (TTM) P/E ratio 28.78
EV/FCF (TTM) EV/FCF 23.47
EV/Sales (TTM) EV/Sales 2.05
P/S ratio (TTM) P/S ratio 1.58
P/B ratio (TTM) P/B ratio 2.52
Dividend yield 1.15%
Last dividend (FY24) $2.88
Revenue growth (TTM) Revenue growth 7.13%
Revenue (TTM) Revenue $13.18b
EBIT (operating result TTM) EBIT $1.14b
Free Cash Flow (TTM) Free Cash Flow $1.15b
Cash position $369.40m
EPS (TTM) EPS $8.67
P/E forward 20.38
P/S forward 1.50
EV/Sales forward 1.94
Short interest 4.57%
Show more

Is Laboratory a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,790 stocks worldwide.

Laboratory Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Laboratory forecast:

19x Buy
83%
4x Hold
17%

Analyst Opinions

23 Analysts have issued a Laboratory forecast:

Buy
83%
Hold
17%

Financial data from Laboratory

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
13,177 13,177
7% 7%
100%
- Direct Costs 9,768 9,768
7% 7%
74%
3,409 3,409
7% 7%
26%
- Selling and Administrative Expenses 1,612 1,612
13% 13%
12%
- Research and Development Expense - -
-
-
1,797 1,797
2% 2%
14%
- Depreciation and Amortization 656 656
1% 1%
5%
EBIT (Operating Income) EBIT 1,142 1,142
3% 3%
9%
Net Profit 731 731
69% 69%
6%

In millions USD.

Don't miss a Thing! We will send you all news about Laboratory directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Laboratory Stock News

Neutral
PRNewsWire
10 days ago
BURLINGTON, N.C., May 8, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that its Annual Meeting of Shareholders will be webcast live on May 15 at 9:00 a.m.
Neutral
Seeking Alpha
19 days ago
Labcorp Holdings Inc. (NYSE:LH ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Christin O'Donnell - Investor Relations Adam Schechter - Chairman & Chief Executive Officer Julia Wang - Executive Vice President & Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Ann Hynes - Mizuho Securities Erin Wright - Morgan Stanley Elizab...
Positive
Reuters
19 days ago
Laboratory operator Labcorp beat analysts' estimate for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
More Laboratory News

Company Profile

Laboratory Corp. of America Holdings is a clinical laboratory company. The firm engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the following segments: LabCorp Diagnostics and Covance Drug Development. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment provides drug development solutions to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.

Head office United States
CEO Adam Schechter
Employees 70,000
Founded 1971
Website www.labcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today